Skip to Main Content

Advertisement

Skip Nav Destination

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes

Blood Adv (2022) 6 (11): 3551–3555.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement